We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Detection Cartridges Expand Modular Platform Applications

By LabMedica International staff writers
Posted on 18 Feb 2009
Four new cartridges for a bioresearch detection platform increase the total number of interchangeable choices to 14, extending platform utility for users of the multimode reader.

The new options for Beckman Coulter's (Fullerton, CA, USA) Paradigm Detection Platform include two additional luminescence detection cartridges optimized for 96- and 384-well plate formats, a new detection cartridge for BRET2 (Bioluminescence Resonance Energy Transfer) live cell assays, and a Rhodamine fluorescence cartridge for a selection of cyanine dyes.

Two of the four new detection cartridges expand the platform's Glow Luminescence line with options designed for 96- and 384-well applications, complementing the existing Glow Luminescence Detection Cartridge optimized for the 1536-well plate format. More...
The well-isolating design of each cartridge is optimized for a specific plate format to provide increased sensitivity with reduced cross talk.

Ideal for the study of protein-protein interactions, the Dual Luminescence Detection Cartridge is optimized for use with BRET2 live cell assays and includes predefined protocols and data analysis tools.

The Fluorescence Intensity Detection Cartridge delivers speed and high sensitivity in applications using Cy3 and equivalent Rhodamine fluorescent labels. This new cartridge expands Beckman Coulter's detection menu for FRET (Fluorescence Resonance Energy Transfer) assays by reading Cy3 paired with Cy5 or Cy5.5 dyes, which are commonly used in genomics and proteomics research.

"The Paradigm platform has been very well-received since its introduction last year and customers value its modularity," explained Alisa Jackson, product manager for Beckman Coulter. "With these new cartridges and others that were previously added, we've almost doubled the detection choices since introduction. We will continue to add cartridges for relevant applications."

Related Links:

Beckman Coulter





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Hematology Consumables
Bioblood Devices
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.